Cash flow Basilea Pharmaceutica AG

Equities

BSLN

CH0011432447

Biotechnology & Medical Research

Market Closed - Swiss Exchange Other stock markets 11:30:56 2026-04-22 am EDT			5-day change	1st Jan Change
54.50 ^CHF	-1.27%		-4.05%	-0.37%

Apr. 15	Basilea Pharmaceutica AG Approves Board and Committee Appointments	CI
Apr. 15	Basilea Pharmaceutica shareholders approve all Board proposals at 2026 AGM	RE

e56885b06eb9.C2a7RYFNLOYZigMLZVQJFl42hmeJ01vEJZ5B6RM8dz8.biHaJ8sieqx0_GhSBm1FWiRz5DW6hBH2Y842j1wRLlFTCpYI6AYVl2H5cA

Published financial data: BASILEA PHARMACEUTICA AG

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	132M	122M	150M	195M	194M
Other Revenues, Total	16.56M	25.45M	7.36M	13.68M	38.02M
Total Revenues	148M	148M	158M	209M	232M
Cost of Goods Sold, Total	117M	98.41M	105M	116M	145M
Gross Profit	30.89M	49.36M	52.99M	92.72M	87.16M
Selling General & Admin Expenses, Total	27.88M	28.54M	31.08M	31.02M	34.91M
Other Operating Expenses, Total	27.88M	28.54M	31.08M	31.02M	34.91M
Operating Income	3.01M	20.81M	21.91M	61.7M	52.25M
Interest Expense, Total	-8.15M	-9.85M	-11.2M	-4.34M	-3.36M
Interest And Investment Income	66K	326K	1.69M	1.42M	1.27M
Net Interest Expenses	-8.08M	-9.52M	-9.51M	-2.93M	-2.09M
Other Non Operating Income (Expenses)	-1.24M	852K	-1.94M	1.49M	-4.29M
EBT, Excl. Unusual Items	-6.31M	12.14M	10.46M	60.26M	45.88M
Gain (Loss) On Sale Of Assets	15K	-	-	-	-
Other Unusual Items	-497K	-41K	-	-	-
EBT, Incl. Unusual Items	-6.79M	12.1M	10.46M	60.26M	45.88M
Income Tax Expense	37K	-45K	10K	-17.33M	5.64M
Earnings From Continuing Operations	-6.83M	12.15M	10.45M	77.59M	40.24M
Net Income to Company	-6.83M	12.15M	10.45M	77.59M	40.24M
Net Income - (IS)	-6.83M	12.15M	10.45M	77.59M	40.24M
Net Income to Common Incl Extra Items	-6.83M	12.15M	10.45M	77.59M	40.24M
Net Income to Common Excl. Extra Items	-6.83M	12.15M	10.45M	77.59M	40.24M
Per Share Items
Net EPS - Basic	-0.58	1.02	0.87	6.42	3.29
Basic EPS - Continuing Operations	-0.58	1.02	0.87	6.42	3.29
Basic Weighted Average Shares Outstanding	11.68M	11.86M	11.99M	12.09M	12.24M
Net EPS - Diluted	-0.58	1.02	0.86	5.82	3.14
Diluted EPS - Continuing Operations	-0.58	1.02	0.86	5.82	3.14
Diluted Weighted Average Shares Outstanding	11.68M	11.94M	12.14M	13.86M	13.68M
Normalized Basic EPS	-0.34	0.64	0.55	3.12	2.34
Normalized Diluted EPS	-0.34	0.64	0.54	2.72	2.1
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	3.56M	21.71M	23.18M	63.13M	54.06M
EBITA	3.01M	20.81M	21.91M	61.7M	52.25M
EBIT	3.01M	20.81M	21.91M	61.7M	52.25M
EBITDAR	5.26M	24.11M	25.48M	65.13M	56.26M
Total Revenues (As Reported)	148M	148M	158M	209M	232M
Effective Tax Rate - (Ratio)	-0.54	-0.37	0.1	-28.76	12.28
Current Foreign Taxes	37K	-45K	10K	-	-
Total Current Taxes	37K	-45K	10K	-	100K
Total Deferred Taxes	-	-	-	-17.33M	5.5M
Normalized Net Income	-3.94M	7.59M	6.54M	37.66M	28.67M
Interest on Long-Term Debt	7.9M	7.2M	3.7M	3.7M	3.3M
Non-Cash Pension Expense	0	-900K	-700K	-500K	-700K
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	93.96M	73.8M	77.85M	77.14M	106M
Net Rental Expense, Total	1.7M	2.4M	2.3M	2M	2.2M
Imputed Operating Lease Interest Expense	481K	931K	1.31M	579K	588K
Imputed Operating Lease Depreciation	1.22M	1.47M	994K	1.42M	1.61M
Stock-Based Comp., COGS (Total)	2.1M	1.6M	2.1M	2.6M	2.2M
Stock-Based Comp., SG&A Exp. (Total)	2.3M	1.7M	2.6M	2.5M	3M
Stock-Based Comp., Other (Total)	-	298K	62K	-34K	38K
Total Stock-Based Compensation	4.4M	3.6M	4.76M	5.07M	5.24M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	53.7M	84.66M	59.93M	121M	160M
Short Term Investments	95M	-	-	-	-
Total Cash And Short Term Investments	149M	84.66M	59.93M	121M	160M
Accounts Receivable, Total	24.95M	33.15M	27.89M	8.88M	13.49M
Other Receivables	39.5M	28.55M	30.26M	49.31M	49.79M
Total Receivables	64.45M	61.7M	58.15M	58.18M	63.28M
Inventory	22.78M	24.24M	26.41M	31.61M	21.56M
Restricted Cash	1.25M	1.91M	4.39M	3.85M	2.54M
Other Current Assets, Total	3.88M	2.85M	3.26M	6.56M	4.56M
Total Current Assets	241M	175M	152M	221M	252M
Gross Property Plant And Equipment	20.72M	37.07M	38.35M	39.08M	40.55M
Accumulated Depreciation	-17.8M	-15.5M	-17.8M	-20.1M	-22.4M
Net Property Plant And Equipment	2.92M	21.57M	20.55M	18.98M	18.15M
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	632K	578K	548K	374K	371K
Loans Receivable Long-Term	2.39M	1.27M	-	-	-
Deferred Tax Assets Long-Term	-	-	-	17.33M	11.7M
Other Long-Term Assets, Total	256K	22.07M	44K	168K	51K
Total Assets	247M	221M	173M	258M	282M
Liabilities
Accounts Payable, Total	10.62M	191K	5.85M	11.49M	15.06M
Accrued Expenses, Total	27.9M	19.3M	13.1M	21.5M	23.9M
Current Portion of Long-Term Debt	124M	37.47M	15.45M	-	-
Current Portion of Leases	896K	1.99M	2.06M	2.06M	2.06M
Current Income Taxes Payable	500K	900K	-	-	-
Unearned Revenue Current, Total	1.23M	1.23M	1.23M	1.62M	1.57M
Other Current Liabilities	9.76M	13.77M	9.9M	8.89M	6.62M
Total Current Liabilities	174M	74.85M	47.59M	45.56M	49.22M
Long-Term Debt	94.54M	131M	95.46M	95.91M	75.44M
Long-Term Leases	10K	16.32M	15.64M	13.7M	11.72M
Unearned Revenue Non Current	11.93M	10.69M	9.46M	11.38M	9.46M
Pension & Other Post Retirement Benefits	24.99M	8.34M	15.15M	10.21M	8.23M
Other Non Current Liabilities	-	-1K	1K	-	-
Total Liabilities	306M	242M	183M	177M	154M
Common Stock, Total	12.99M	13.09M	13.1M	13.17M	13.32M
Additional Paid In Capital	1.03B	1.04B	1.04B	1.05B	1.05B
Retained Earnings	-1.02B	-1.01B	-1B	-923M	-883M
Treasury Stock	-56.56M	-56.07M	-54.01M	-51.7M	-51.28M
Comprehensive Income and Other	-21.62M	-3.78M	-10.21M	-4.74M	-3.9M
Total Common Equity	-58.61M	-20.72M	-10M	81M	128M
Total Equity	-58.61M	-20.72M	-10M	81M	128M
Total Liabilities And Equity	247M	221M	173M	258M	282M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	11.84M	11.95M	12M	12.13M	12.29M
ECS Total Common Shares Outstanding	11.84M	11.95M	12M	12.13M	12.29M
Book Value / Share	-4.95	-1.73	-0.83	6.68	10.41
Tangible Book Value	-59.24M	-21.29M	-10.55M	80.62M	128M
Tangible Book Value Per Share	-5	-1.78	-0.88	6.65	10.38
Total Debt	219M	187M	129M	112M	89.22M
Net Debt	70.26M	102M	68.67M	-9.04M	-70.58M
Debt Equivalent of Unfunded Proj. Benefit Obligation	25M	8.3M	15.2M	10.2M	8.2M
Debt Equivalent Oper. Leases	13.6M	19.2M	18.4M	16M	17.6M
Account Code - Inventory Valuation	5	5	5	5	3
Inventories - Raw Materials, Total	2M	2M	800K	2.6M	200K
Inventories - Work In Process, Total	32.48M	38.84M	39.51M	43.01M	33.46M
Inventories - Finished Goods, Total	200K	1.1M	500K	1.3M	1.4M
Land - (BS)	-	-	-	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	16.62M	12.98M	12.86M	13.61M	14.85M
Full Time Employees	154	141	147	164	189

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-6.83M	12.15M	10.45M	77.59M	40.24M
Depreciation & Amortization - CF	2.25M	2.7M	3.18M	3.23M	3.71M
Depreciation & Amortization, Total	2.25M	2.7M	3.18M	3.23M	3.71M
Amortization of Deferred Charges, Total - (CF)	1.3M	1.1M	1.74M	900K	588K
(Gain) Loss From Sale Of Asset	-71K	-	-	1.02M	-
Stock-Based Compensation (CF)	4.32M	3.6M	4.76M	5.07M	5.24M
Other Operating Activities, Total	-1.21M	-763K	-1.57M	-19.74M	3.54M
Change In Accounts Receivable	-16.25M	-8.24M	5.23M	19.02M	-4.62M
Change In Inventories	-1.59M	-1.46M	-2.17M	-5.2M	10.05M
Change In Accounts Payable	-2.54M	-10.43M	5.66M	5.64M	3.57M
Change in Unearned Revenues	-2.56M	-1.23M	-1.23M	2.31M	-1.97M
Change in Other Net Operating Assets	-8.85M	9.64M	-11.8M	-15.48M	1.73M
Cash from Operations	-32.02M	7.06M	14.24M	74.36M	62.09M
Capital Expenditure	-581K	-3.14M	-813K	-1.71M	-2.62M
Sale of Property, Plant, and Equipment	15K	-	-	-	-
Divestitures	-1.6M	-	-	781K	-
Sale (Purchase) of Intangible assets	-279K	-165K	-221K	-82K	-242K
Investment in Marketable and Equity Securities, Total	6.02M	94.95M	-	-	-
Other Investing Activities, Total	-	1K	-	-	-
Cash from Investing	3.58M	91.65M	-1.03M	-1.01M	-2.86M
Long-Term Debt Issued, Total	-	73.88M	-	-	-
Total Debt Issued	-	73.88M	-	-	-
Long-Term Debt Repaid, Total	-	-	-59.31M	-15.6M	-
Total Debt Repaid	-	-	-59.31M	-15.6M	-
Issuance of Common Stock	44.11M	4.43M	2.48M	2.46M	692K
Repurchase of Common Stock	-4.25M	-	-	-	-
Other Financing Activities, Total	-23.21M	-124M	-472K	-21K	-22.12M
Cash from Financing	16.64M	-45.25M	-57.3M	-13.16M	-21.42M
Foreign Exchange Rate Adjustments	501K	155K	-151K	50K	-26K
Net Change in Cash	-11.3M	53.61M	-44.24M	60.24M	37.78M
Supplemental Items
Cash Interest Paid	7.07M	6.33M	9.76M	3.73M	3.04M
Cash Income Tax Paid (Refund)	35K	4K	7K	-	-
Levered Free Cash Flow	-25.13M	-2.01M	8.51M	48.68M	49.16M
Unlevered Free Cash Flow	-21.14M	3.25M	14.07M	50.8M	50.67M
Change In Net Working Capital	29.01M	12.95M	6.82M	-5.43M	-11.92M
Net Debt Issued / Repaid	-	73.88M	-59.31M	-15.6M	-

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	0.79	5.56	6.95	17.89	12.1
Return on Total Capital	1.25	7.96	9.61	24.78	15.94
Return On Equity %	8.5	-30.63	-68.04	218.58	38.52
Return on Common Equity	8.5	-30.63	-68.04	218.58	38.52
Margin Analysis
Gross Profit Margin %	20.86	33.4	33.61	44.46	37.51
SG&A Margin	18.83	19.32	19.72	14.88	15.02
EBITDA Margin %	2.4	14.69	14.71	30.27	23.26
EBITA Margin %	2.03	14.09	13.9	29.59	22.48
EBIT Margin %	2.03	14.09	13.9	29.59	22.48
Income From Continuing Operations Margin %	-4.61	8.22	6.63	37.21	17.32
Net Income Margin %	-4.61	8.22	6.63	37.21	17.32
Net Avail. For Common Margin %	-4.61	8.22	6.63	37.21	17.32
Normalized Net Income Margin	-2.66	5.14	4.15	18.06	12.34
Levered Free Cash Flow Margin	-16.97	-1.36	5.4	23.34	21.15
Unlevered Free Cash Flow Margin	-14.27	2.2	8.93	24.36	21.8
Asset Turnover
Asset Turnover	0.62	0.63	0.8	0.97	0.86
Fixed Assets Turnover	36.14	12.07	7.48	10.55	12.52
Receivables Turnover (Average Receivables)	7.82	4.21	4.92	10.6	17.38
Inventory Turnover (Average Inventory)	5.33	4.19	4.13	3.99	5.46
Short Term Liquidity
Current Ratio	1.38	2.34	3.2	4.85	5.11
Quick Ratio	1.22	1.96	2.48	3.93	4.53
Operating Cash Flow to Current Liabilities	-0.18	0.09	0.3	1.63	1.26
Days Sales Outstanding (Average Receivables)	46.69	86.69	74.13	34.53	21
Days Outstanding Inventory (Average Inventory)	68.46	87.21	88.34	91.67	66.82
Average Days Payable Outstanding	36.51	19.75	10.32	26.21	35.84
Cash Conversion Cycle (Average Days)	78.64	154.15	152.16	99.99	51.98
Long Term Solvency
Total Debt/Equity	-373.6	-903.39	-1.29K	137.87	69.73
Total Debt / Total Capital	136.55	112.45	108.43	57.96	41.08
LT Debt/Equity	-161.34	-712.93	-1.11K	135.32	68.12
Long-Term Debt / Total Capital	58.97	88.74	93.67	56.89	40.13
Total Liabilities / Total Assets	123.7	109.38	105.77	68.58	54.63
EBIT / Interest Expense	0.37	2.11	1.96	14.2	15.56
EBITDA / Interest Expense	0.65	2.45	2.28	14.99	16.76
(EBITDA - Capex) / Interest Expense	0.57	2.13	2.2	14.6	15.98
Total Debt / EBITDA	41.61	7.76	5.05	1.71	1.59
Net Debt / EBITDA	13.35	4.25	2.69	-0.14	-1.25
Total Debt / (EBITDA - Capex)	46.78	8.92	5.21	1.76	1.66
Net Debt / (EBITDA - Capex)	15.01	4.89	2.78	-0.14	-1.32
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.06	-0.24	6.68	32.3	11.43
Gross Profit, 1 Yr. Growth %	401.1	59.77	7.35	74.98	-5.99
EBITDA, 1 Yr. Growth %	-117.53	509.49	6.79	172.29	-14.77
EBITA, 1 Yr. Growth %	-114.05	591.92	5.26	181.62	-15.32
EBIT, 1 Yr. Growth %	-114.05	591.92	5.26	181.62	-15.32
Earnings From Cont. Operations, 1 Yr. Growth %	-53.6	-277.82	-13.96	642.45	-48.14
Net Income, 1 Yr. Growth %	-53.6	-277.82	-13.96	642.45	-48.14
Normalized Net Income, 1 Yr. Growth %	-78.52	-292.38	-13.56	476.04	-23.87
Diluted EPS Before Extra, 1 Yr. Growth %	-59.16	-274.43	-15.69	577.28	-46.05
Accounts Receivable, 1 Yr. Growth %	186.42	32.89	-15.87	-68.18	51.99
Inventory, 1 Yr. Growth %	7.51	6.41	8.93	19.69	-31.8
Net Property, Plant and Equip., 1 Yr. Growth %	-44.59	637.97	-4.72	-7.66	-4.36
Total Assets, 1 Yr. Growth %	7.6	-10.68	-21.53	48.75	9.4
Tangible Book Value, 1 Yr. Growth %	-42.33	-64.06	-50.45	-864.15	58.23
Common Equity, 1 Yr. Growth %	-42.57	-64.65	-51.71	-909.75	57.95
Cash From Operations, 1 Yr. Growth %	-40.85	-122.04	101.88	422.03	-16.5
Capital Expenditures, 1 Yr. Growth %	-68.13	440.1	-74.09	110.33	53.22
Levered Free Cash Flow, 1 Yr. Growth %	-45.4	-92.04	-447.54	471.79	0.98
Unlevered Free Cash Flow, 1 Yr. Growth %	-50.25	-115.31	333.12	260.98	-0.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.99	7.6	3.16	18.8	21.42
Gross Profit, 2 Yr. CAGR %	55.05	182.95	30.97	37.06	28.26
EBITDA, 2 Yr. CAGR %	-49.78	3.36	155.13	70.52	52.7
EBITA, 2 Yr. CAGR %	-56.18	-1.41	169.87	72.17	54.43
EBIT, 2 Yr. CAGR %	-56.18	-1.41	169.87	72.17	54.43
Earnings From Cont. Operations, 2 Yr. CAGR %	-44.8	-9.17	23.69	152.74	96.22
Net Income, 2 Yr. CAGR %	-44.8	-9.17	23.69	152.74	96.22
Normalized Net Income, 2 Yr. CAGR %	-46.9	-35.72	28.74	123.14	109.41
Diluted EPS Before Extra, 2 Yr. CAGR %	-47.04	-15.6	21.27	138.96	91.15
Accounts Receivable, 2 Yr. CAGR %	99.92	95.09	5.74	-48.26	-30.45
Inventory, 2 Yr. CAGR %	10.77	6.96	7.67	14.18	-9.65
Net Property, Plant and Equip., 2 Yr. CAGR %	-30.56	102.22	165.16	-6.2	-6.03
Total Assets, 2 Yr. CAGR %	5.66	-1.97	-16.29	8.03	27.57
Tangible Book Value, 2 Yr. CAGR %	-20.33	-54.47	-57.8	94.59	247.72
Common Equity, 2 Yr. CAGR %	-20.6	-54.94	-58.69	97.74	257.63
Cash From Operations, 2 Yr. CAGR %	-29.18	-63.9	-33.3	224.64	108.78
Capital Expenditures, 2 Yr. CAGR %	40.58	31.2	18.29	-26.18	79.52
Levered Free Cash Flow, 2 Yr. CAGR %	150.77	-79.12	-41.89	345.78	140.28
Unlevered Free Cash Flow, 2 Yr. CAGR %	420.04	-72.35	-18.56	295.4	89.75
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.77	3.22	7.29	12.08	16.29
Gross Profit, 3 Yr. CAGR %	61.65	56.61	104.84	44.25	20.87
EBITDA, 3 Yr. CAGR %	-45	15.4	4.49	160.72	35.54
EBITA, 3 Yr. CAGR %	-49.36	9.93	0.77	173.74	35.91
EBIT, 3 Yr. CAGR %	-49.36	9.93	0.77	173.74	35.91
Earnings From Cont. Operations, 3 Yr. CAGR %	-39.83	-18.48	-10.79	124.79	49.07
Net Income, 3 Yr. CAGR %	-39.83	-18.48	-10.79	124.79	49.07
Normalized Net Income, 3 Yr. CAGR %	-41.27	-18.44	-29.13	112.14	55.92
Diluted EPS Before Extra, 3 Yr. CAGR %	-41.31	-21.2	-15.63	115.16	45.5
Accounts Receivable, 3 Yr. CAGR %	87.96	74.47	47.39	-29.14	-25.9
Inventory, 3 Yr. CAGR %	16.49	9.3	7.61	11.53	-3.84
Net Property, Plant and Equip., 3 Yr. CAGR %	-23.09	52.67	57.35	86.56	-5.59
Total Assets, 3 Yr. CAGR %	-4.26	-0.09	-8.98	1.4	8.49
Tangible Book Value, 3 Yr. CAGR %	-4.05	-38.9	-53.17	10.82	81.62
Common Equity, 3 Yr. CAGR %	-4.21	-39.37	-53.89	11.39	83.47
Cash From Operations, 3 Yr. CAGR %	-26.06	-52.01	-35.92	32.43	106.45
Capital Expenditures, 3 Yr. CAGR %	11.51	120.18	-23.6	43.31	-5.84
Levered Free Cash Flow, 3 Yr. CAGR %	-16.05	-20.53	-43.02	24.53	171.74
Unlevered Free Cash Flow, 3 Yr. CAGR %	-18.6	60.79	-30.81	33.78	149.84
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	17.55	7.8	3.53	9.19	12.73
Gross Profit, 5 Yr. CAGR %	20.44	5.68	48.6	48.47	69.86
EBITDA, 5 Yr. CAGR %	-38.85	12.13	1.61	34.91	21.62
EBITA, 5 Yr. CAGR %	-41.5	8.04	-1.1	31.54	19.53
EBIT, 5 Yr. CAGR %	-41.5	8.04	-1.1	31.54	19.53
Earnings From Cont. Operations, 5 Yr. CAGR %	-33.18	-8.9	-19.73	28.18	22.28
Net Income, 5 Yr. CAGR %	-33.18	-8.9	-19.73	28.18	22.28
Normalized Net Income, 5 Yr. CAGR %	-34.14	-8.59	-19.61	21.91	9.32
Diluted EPS Before Extra, 5 Yr. CAGR %	-35.08	-10.64	-21.54	22.81	17.02
Accounts Receivable, 5 Yr. CAGR %	58.52	46.25	49.32	7.29	9.15
Inventory, 5 Yr. CAGR %	8.82	9.61	12.88	11.23	0.34
Net Property, Plant and Equip., 5 Yr. CAGR %	-19.92	22.66	26.19	25.64	28.04
Total Assets, 5 Yr. CAGR %	-5.48	-8.86	-9.26	3.08	4.18
Tangible Book Value, 5 Yr. CAGR %	10.95	-12.61	-30.92	-2.88	4.43
Common Equity, 5 Yr. CAGR %	10.86	-12.95	-31.57	-2.72	4.63
Cash From Operations, 5 Yr. CAGR %	-15.65	-17.98	-29.05	3.1	2.78
Capital Expenditures, 5 Yr. CAGR %	8.08	34.57	14.18	42.21	7.52
Levered Free Cash Flow, 5 Yr. CAGR %	-0.63	-6.12	-27.49	64.87	1.32
Unlevered Free Cash Flow, 5 Yr. CAGR %	-1.44	39.23	-18.52	130.45	3.59